Skip to content
A Blog by Biocon

A Blog by Biocon

  • Home
  • About Us
  • Biocon Biologics
    • Biosimilars
    • Biocon Biologics @ IDF Congress 2019
      • Speaker Profiles
    • Itolizumab (ALZUMAb®) : Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19
  • Healthcare
  • Innovation
  • Disease Epidemiology
  • Vodcast
  • Bioconites Corner
    • Work From Home
    • Campaigns
      • Har Ghar Tiranga
      • Mother’s Day
      • Lupus Day
  • Policy
  • Comments Policy
  • Contact

Tag: Antimicrobial Resistance (AMR)

October 3, 2016October 3, 2016 Biocon Innovation

Antimicrobial Resistance (AMR) – A global threat is here to stay!

Antimicrobial resistance (AMR) represents a global catastrophe that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

Biocon Employees come together to sing our National Anthem to mark 75th Independence Day.

Itolizumab: Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19

DCGI Approval for emergency use of Itolizumab in treatment of Covid-19

Follow Biocon Biologics

BBL-X
BBL-Li
BBL-fb
BBL-Inst

Follow Biocon

Search

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Archives

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • A Blog by Biocon
    • Join 116 other subscribers
    • Already have a WordPress.com account? Log in now.
    • A Blog by Biocon
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...